VALEO overview

Golden Minerals Company CEO Warren Rehn tells Proactive it has announced a 38% sequential increase in its third-quarter 2021 payable production to 4942 ......

/C O R R E C T I O N from Source -- Valeo Pharma inc./ PR Newswire MONTREAL, Oct. 13, 2021 In the news release, Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada, issued 13-Oct-2021 by Valeo Pharma inc. over CNW, we are advised by the company that the headline was changed, it shoud read "Valeo Pharma Obtains Listings for Redesca from Two GPO Representing 700 Hospitals and Healthcare Facilities Across Canada" rather than "Valeo Pharma Obtains...

Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada PR Newswire MONTREAL, Oct. 13, 2021 2 Group Purchasing Organizations (GPO) listing agreements cover, Redesca™ and Redesca HP™, as well as 3 other Valeo hospital products The 2 multi-year product listings commenced on October 1, 2021 The GPOs together represent more than 700 hospitals and healthcare facilities across 5 provinces including Ontario MONTREAL , Oct. 13, 2021 /PRNewswire/ - Valeo...

Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler® PR Newswire MONTREAL, Oct. 5, 2021 Agreement to provide framework to participating jurisdictions in support of provincial public listings and reimbursements of both drugs Private payer health plan coverage exceeds 85% across Canada Scientific community demonstrates growing interest in both products MONTREAL , Oct. 5, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE:...

Vicinity Motor Corp. CEO William Trainer tells Proactive the supplier of electric, CNG, gas and clean diesel vehicles has received over $15.5 million in new ......

Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™ and Redesca HP™ PR Newswire MONTREAL, July 13, 2021 Redesca™ and Redesca HP™ now covered for public reimbursement in 7 provinces and territories across Canada Private payer health plan coverage in Canada now at 70% MONTREAL , July 13, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE:VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, announced today that Redesca™...

ioneer Ltd's (ASX:INR) (OTCMKTS:GSCCF) Bernard Rowe caught up with Proactive's Andrew Scott soon after announcing they've signed their first binding ......

Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast PR Newswire MONTREAL, June 23, 2021 MONTREAL , June 23, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE:VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, announced today that it will report its financial results and highlights for the second quarter ended April 30, 2021 on Tuesday June 29, 2021 after market close. Valeo will host a conference call to discuss...

Valeo Pharma (CSE: VPH – OTCQB: VPHIF) CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has started the ......

Valeo Pharma Announces Commercial Launch of Enerzair® Breezhaler® and Atectura® Breezhaler® PR Newswire MONTREAL, June 22, 2021 Product shipments have commenced across Canada National respiratory sales force recruitment well advanced, field deployment on-going Private and public reimbursement coverage progressing Nelly Komari , joins Valeo as Senior Vice President Scientific & Medical Affairs MONTREAL , June 22, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("...

Datametrex AI Limited (TSXV:DM) (OTCQB:DTMXF) CEO Marshall Gunter tells Proactive the Toronto, Canada-based artificial intelligence mining company has ......

Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® PR Newswire MONTREAL, June 1, 2021 Private payer health plan coverage in Canada for Enerzair Breezhaler and Atectura Breezhaler has reached 80% Reimbursement proceedings with publicly funded health plans ready to commence MONTREAL , June 1, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company,...

Valeo Pharma Projecting Record Revenues for Second Quarter 2021 PR Newswire MONTREAL, May 26, 2021 Record revenues and margins expected for Q2-21 Redesca® launch beginning to impact financial performance Respiratory sales force infrastructure well advanced in support of coming Enerzair® Breezhaler® and Atectura® Breezhaler® commercial launch MONTREAL , May 26, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian...

Valeo Pharma (CSE: VPH-OTCQB: VPHIF) CEO Steve Saviuk joined Steve Darling from Proactive to bring news the Ontario Public Drug Program has said they ......

Valeo Pharma's Redesca® and Redesca HP® to Be Covered Under the Ontario Public Drug Benefit Program PR Newswire MONTREAL, April 28, 2021 Ontario represents 37% of the Canadian low molecular weight heparin market Additional provincial coverage expected to follow MONTREAL , April 28, 2021 /PRNewswire/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, today announced that it has entered into a Product Listing Agreement...